Biotech

All Articles

Biogen's chief executive officer claimed no dangerous handle 2023. He's ready to be vibrant

.While Biogen's pharma peers are actually seeking for late-stage resources along with little danger,...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has been actually a biotech searching for a pipeline after it scrapped its own lead poss...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually returned legal rights to a very early Alzheimer's disease system to Denali Ther...

Takeda touches new mind people oncology service-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and als...

Vertex, hammered through AATD again, drops 2 properties on throw away pile

.Vertex's effort to address an uncommon genetic ailment has actually hit an additional problem. The ...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter profits record wasn't except big headlines. The business invited...

Galapagos pauses CAR-T tissue therapy litigation over Parkinsonism case

.Galapagos has stopped briefly registration in a trial of a BCMA-directed CAR-T cell treatment, pump...

James Wilson leaving behind Penn to launch two brand-new biotechs

.After greater than 30 years, genetics treatment trendsetter James Wilson M.D., Ph.D., is leaving th...

3 biotechs attempt to defeat the summertime warm by losing team

.As biotechs try to turn a new webpage in August, a minimum of 3 companies have actually shed staff ...

venBio raises $528M for 5th lifestyle sciences VC fund

.Veteran financial backing organization venBio has raised another half a billion bucks to acquire bi...